Showing 2141-2150 of 5615 results for "".
Hospital Owned Medical Practices: Tips for Success
https://reachmd.com/programs/clinicians-roundtable/hospital-owned-medical-practices-tips-for-success/3478/As hospitals get back into the game of owning and running medical practices what must they do to succeed? Our guest Marc Halley, president of Halley Consulting Group, a firm specializing in services to hospital-owned primary care networks shares with host Dr. Larry Kaskel his 8 initiatives for succWomen in Leadership in Healthcare: Perspectives from Army Medicine
https://reachmd.com/programs/the-strength-to-heal/leadership-in-healthcare-lessons-from-army-medicine/3315/Maj. Gen. Dr. Carla Hawley-Bowland, commanding general at Walter Reed Army Medical Center, chief of the United States Army Medical Corps, and the first female Medical Corps General in the history of the United States Army, speaks about the leadership structure that afforded her the opportunity to asMass Casualty Management: Lessons from Army Medicine
https://reachmd.com/programs/the-strength-to-heal/mass-casualty-management-lessons-from-army-medicine/3265/Maj. Dr. Colin Meghoo, a general surgeon at Landstuhl Regional Medical Center in Germany, shares experiences in mass casualty management from Iraq with host Dr. John Armstrong. For care providers, a team-oriented approach is essential to expeditiously and safely treat a never-ending stream of patienTeam Doc: Pressure from Players & Coaches
https://reachmd.com/programs/focus-on-sports-medicine/team-doc-pressure-from-players-coaches/3209/When a team's best player gets injured in the final minutes of a crucial playoff game, the most pivotal person in the stadium may be that team's lead physician. How does the responsibilities of a team physician change based on the specific injury, the player and the game situation? What are the respThe Prematurity Epidemic: Controversies, Research
https://reachmd.com/programs/clinicians-roundtable/the-prematurity-epidemic-controversies-research/1705/Magnesium has been used for the past two decades for treatment of pre-term labor. Yet there is doubt about its therapeutic value for this purpose and it has significant maternal morbidity. What else is changing in the management and treatment of pre-term labor? Our guest is Dr. Jay Iams whoPre-Term Birth in the US: A Growing Epidemic
https://reachmd.com/programs/clinicians-roundtable/pre-term-birth-in-the-us-a-growing-epidemic/1702/According to a recent Institute of Medicine report preterm birth has increased by 30% over the past 25 years in the United States. Birth before 37 completed weeks now comprises 12.5% of all US births and poses a major public health problem and expense. Why is the rate of prematurity increasing eveWhy Participating in Improvement Activities Matters
https://reachmd.com/programs/perspectives-ama/why-participating-improvement-activities-matters/8366/An overview of the Improvement Activities, category, including how the activities may be reported and scored by CMS.IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
https://reachmd.com/programs/cme/ibd-masterclass-foundations-of-pathophysiology-and-targeted-therapy/49149/Examine the biological mechanisms underlying IBD, including genetic, microbial, environmental, and immune pathways that inform therapeutic targets.Integrating Perspectives: The Value of Patient and Caregiver Input
https://reachmd.com/programs/cme/integrating-perspectives-the-value-of-patient-and-caregiver-input/35883/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
https://reachmd.com/programs/cme/vous-prescrivez-uniquement-des-antihistaminiques-pour-traiter-les-patients-atteints-de-pa-mrc-il-est-temps-de-revoir-votre-approche/56888/Examinez un cas clinique réel de Pa-MRC et explorez les options thérapeutiques actuelles, y compris l’utilisation de la difélikéfaline, recommandée par les lignes directrices, chez les patients sous hémodialyse.